Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial

Laurent Fauchier, Nicolas Lamblin, Jean Tardu (), Lucile Bellier, Harinala Groyer, Deborah Ittah, Julien Chollet, Stephan Linden and Pierre Levy
Additional contact information
Laurent Fauchier: Université de Tours
Nicolas Lamblin: Université de Lille
Jean Tardu: Creativ-Ceutical
Lucile Bellier: Creativ-Ceutical
Harinala Groyer: Boehringer Ingelheim France
Deborah Ittah: Boehringer Ingelheim France
Julien Chollet: Boehringer Ingelheim France
Stephan Linden: Boehringer Ingelheim France
Pierre Levy: Université Paris Dauphine, Université PSL, LEDA [LEGOS]

PharmacoEconomics - Open, 2024, vol. 8, issue 1, No 3, 19-30

Abstract: Abstract Introduction The efficacy and safety of empagliflozin in the treatment of heart failure with preserved ejection fraction (HFpEF) were demonstrated in the EMPEROR-Preserved trial, which showed a 21% reduction in combined risks of cardiovascular death or HF hospitalization [hazard ratio (HR) 0.79; 95% confidence interval (CI) 0.69–0.90, p

Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-023-00432-z Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:8:y:2024:i:1:d:10.1007_s41669-023-00432-z

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-023-00432-z

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().